Muhammad Rosli, one half of a pair of conjoined twins whose separation became a defining moment in Malaysian medical history, passed away this morning at Chancellor Tuanku Muhriz Hospital in Kuala Lumpur. The news was announced by his twin brother Ahmad through a social media post, confirming that Muhammad died at 10:45 am local time. His remains were laid to rest at the USJ 22 Muslim Cemetery in Subang Jaya later that evening, bringing to a close the remarkable life of a man whose birth and subsequent medical journey had captivated the nation for more than two decades.
The twin brothers achieved international recognition when they underwent what many observers hailed as a surgical breakthrough in September 2002. Working at the King Fahd National Guard Hospital in Riyadh, Saudi Arabia, a multinational team of surgeons undertook an extraordinarily delicate 22-hour and 45-minute procedure to safely separate the boys, who had been born joined at the liver. Prior to this landmark operation, the twins had already undergone initial preparatory work at the University Malaya Medical Centre in Kuala Lumpur during 2001, where surgeons had conducted a liver-splitting procedure to increase the likelihood of successful separation. The operation in Riyadh represented the culmination of months of meticulous planning and represented a triumph of modern surgical expertise and international medical collaboration.
Muhammad's final illness emerged as a significant health challenge when he was diagnosed with bladder cancer. Beginning in July 2025, he sought treatment at the same Saudi Arabian hospital where his separation surgery had taken place decades earlier, creating a poignant full-circle moment for the family. The malignancy proved aggressive, requiring intensive medical intervention. Records indicate that Muhammad endured five separate surgical procedures aimed at removing or managing the cancerous growth, supplemented by five cycles of chemotherapy designed to halt the disease's progression. Despite the rigorous treatment regimen, the cancer appears to have taken an inexorable toll on his body over the intervening weeks.
According to his brother's account, Muhammad's clinical status began deteriorating markedly in recent days. Ahmad disclosed that Muhammad's blood acid levels had risen to dangerous heights, a condition that left him in a semi-conscious state and indicated that his organs were struggling to maintain equilibrium. This metabolic complication, often associated with advanced malignancy or organ dysfunction, signalled a critical turning point in his deteriorating health. The family had maintained hope through the initial phases of treatment, supported by prayers and well-wishes from across Malaysia and beyond, but the severity of his condition in his final hours made clear that recovery was no longer feasible.
The separation of Muhammad and Ahmad represented more than a purely medical achievement; it captured the imagination of Malaysians during the early 2000s and underscored the nation's capacity to engage international expertise for complex healthcare challenges. The case drew attention to Malaysia's medical infrastructure and demonstrated that world-class surgical capabilities existed within reach. News coverage of the twins' successful separation had been extensive, with the operation regarded as a triumph not only for the surgeons involved but for modern medicine's capacity to address congenital conditions once thought inseparable. The twin brothers became ambassadors of sorts for Malaysian healthcare aspiration during an era when such international medical collaborations were less common.
The loss of Muhammad also reflects the ongoing vulnerabilities that individuals born with congenital conditions may face throughout their lives. While the separation surgery had granted both brothers the opportunity to live relatively independent existences for more than two decades following 2002, the emergence of cancer in Muhammad's case underscores the reality that childhood medical interventions, however successful, do not guarantee freedom from future health challenges. The complexity of his condition and the aggressive nature of his malignancy required sustained, intensive treatment even with access to modern oncological care. His passing serves as a sobering reminder of the ongoing health struggles that may confront individuals who have survived major early-life surgical procedures.
Ahmad's decision to share news of his brother's death through a public Facebook announcement reflected the deep connection between the twins and their public profile. The brief statement, expressed in formal and respectful language, acknowledged the family's faith and expressed gratitude for the prayers and support that had been extended to Muhammad throughout his illness. The phrasing suggested a family bound by profound shared experience—the twins had literally been inseparable at birth and had undergone transformative surgery together as young boys. Their interdependence during those formative years, and their subsequent lives as separate individuals, had created a unique emotional and familial dynamic that extended through adulthood.
The medical establishment in Malaysia will likely reflect on Muhammad's case as part of the broader narrative of the country's healthcare achievements. The initial surgery in 2001-2002 had positioned Malaysian medicine on an international stage and attracted visiting surgeons and medical delegations interested in understanding how the procedure had been accomplished. Universities and teaching hospitals had leveraged the case for educational purposes, with the twins' experience becoming part of medical school curricula and hospital case study archives. That one of the twins could pass away from a separate, subsequently acquired illness highlights the distinction between addressing congenital abnormalities and managing the unpredictable health challenges that emerge across a full human lifespan.
For Ahmad, the loss is particularly significant given the twins' intertwined history and the probability that their bond remained emotionally central to both their identities. Growing up as conjoined twins in Malaysia during the 1980s and 1990s, then experiencing the profound trauma and triumph of separation surgery as young children, had forged a connection that transcended the merely biological. Ahmad's public announcement of his brother's passing carried an undertone of both grief and gratitude—grief for the loss of his twin, but also acknowledgment of the prayers and compassion extended by the Malaysian community and beyond. The brothers had shared a medical odyssey that few people could truly comprehend, and Muhammad's death represents the severing of that deeply personal connection.
Muhammad's death closes a significant chapter in Malaysian medical history while also serving as a poignant denouement to a personal story of resilience and survival. The twin brothers' 2002 separation had represented hope and possibility, demonstrating that even the most challenging medical conditions could be addressed through expertise, innovation, and determination. Yet life's trajectory is never guaranteed, and Muhammad's diagnosis and subsequent death from cancer, unrelated to his congenital condition, underscores the fragility of human existence. His memory will likely endure in Malaysia's medical archives and in the recollections of those who followed his extraordinary journey from conjoined infancy through successful separation to adulthood, even as his passing marks the end of one of the nation's most remarkable personal medical stories.
